⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17627651 | 1.00 | — | — | |
| SCHEMBL6761885 | 1.00 | — | — | |
| SCHEMBL154656 | 1.00 | — | — | |
| SCHEMBL154655 | 1.00 | — | — | |
| SCHEMBL18316484 | 1.00 | — | — | |
| SCHEMBL6761880 | 0.79 | — | — | |
| SCHEMBL6761877 | 0.79 | — | — | |
| SCHEMBL6762913 | 0.79 | — | — | |
| SCHEMBL6761907 | 0.74 | — | — | |
| SCHEMBL6761909 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4214303-B1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2026-05-06 | — | — | EP | claimed |
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | claimed |
| US-12522786-B2 | Organic compounds | GIVAUDAN SA (CH) | 2026-01-13 | — | — | US | claimed |
| WO-2025202258-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-10-02 | — | — | WO | claimed |
| EP-3325588-B1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-16 | — | — | EP | claimed |
| US-12251454-B2 | Perfume compositions | GIVAUDAN SA (CH) | 2025-03-18 | — | — | US | claimed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| WO-2024213536-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | claimed |
| CN-107072911-B | Malodor reducing compositions | 奇华顿股份有限公司 | 2020-12-29 | — | — | CN | claimed |
| US-20190336413-A1 | Perfume Compositions | GIVAUDAN SA (CH) | 2019-11-07 | — | — | US | claimed |
| EP-3534730-A2 | COMPOSITION USEFUL TO SIMULATE TOBACCO AROMA | British American Tobacco (Investments) Limited (GB) | 2019-09-11 | — | — | EP | claimed |
| US-10238592-B2 | Organic compounds | GIVAUDAN S.A. (CH) | 2019-03-26 | — | — | US | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-20170181945-A1 | Improvements in or Relating to Organic Compounds | GIVAUDAN S.A. (CH) | 2017-06-29 | — | — | US | claimed |
| EP-3137049-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2017-03-08 | — | — | EP | claimed |
| WO-2015165582-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2015-11-05 | — | — | WO | claimed |
| EP-1937365-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | Givaudan SA (CH) | 2008-07-02 | — | — | EP | claimed |
| WO-2007025402-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | GIVAUDAN SA (CH) | 2007-03-08 | — | — | WO | claimed |